标题
Anti-platelet therapy: ADP receptor antagonists
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 4, Pages 647-657
出版商
Wiley
发表日期
2011-04-26
DOI
10.1111/j.1365-2125.2011.03999.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention
- (2011) Young-Guk Ko et al. AMERICAN HEART JOURNAL
- Extracellular Ca2+ modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation
- (2011) Sarah Jones et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ticagrelor
- (2011) James J. Nawarskas et al. Cardiology in Review
- Pharmacokinetics and the antiplatelet effect of a new clopidogrel formulation, clopidogrel besylate, in healthy subjects
- (2011) J.-Y. Park et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Initial Experiment With Personalized Antiplatelet Therapy
- (2011) Paul A. Gurbel JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel
- (2011) Bas JM Peters et al. PHARMACOGENOMICS
- P2Y12and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP
- (2011) David Iyú et al. PLATELETS
- P2Y12 receptor in platelet activation
- (2011) Soochong Kim et al. PLATELETS
- Signaling During Platelet Adhesion and Activation
- (2010) Zhenyu Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y 12 Antagonist
- (2010) David Iyú et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Benzofuran-substituted urea derivatives as novel P2Y1 receptor antagonists
- (2010) Reema K. Thalji et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
- (2010) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyond
- (2010) Hong-Guang Xie et al. PHARMACOLOGY & THERAPEUTICS
- The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y12receptor inhibition
- (2010) Juergen Koessler et al. PLATELETS
- The P2X1ion channel in platelet function
- (2010) Hu Hu et al. PLATELETS
- Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy
- (2010) Sébastien Arméro et al. PLATELETS
- Clopidogrel non-responsiveness and risk of cardiovascular morbidity
- (2010) Rossella Marcucci et al. THROMBOSIS AND HAEMOSTASIS
- Mode of action of P2Y12 antagonists as inhibitors of platelet function
- (2010) D. Iyú et al. THROMBOSIS AND HAEMOSTASIS
- Antagonists of the EP3Receptor for Prostaglandin E2Are Novel Antiplatelet Agents That Do Not Prolong Bleeding
- (2009) Jasbir Singh et al. ACS Chemical Biology
- Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist
- (2009) Steen Husted et al. Cardiovascular Therapeutics
- Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention
- (2009) Marco Valgimigli et al. CIRCULATION
- Bedside Evaluation of Thienopyridine Antiplatelet Therapy
- (2009) Matthew J. Price CIRCULATION
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study
- (2009) Horst Neubauer et al. Clinical Research in Cardiology
- Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: A randomized, open-label, crossover study in healthy Korean male subjects
- (2009) Sung-Doo Kim et al. CLINICAL THERAPEUTICS
- New P2Y12 antagonists
- (2009) Alan D Michelson CURRENT OPINION IN HEMATOLOGY
- P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use
- (2009) L. Wallentin EUROPEAN HEART JOURNAL
- The P2Y12Antagonists, 2-Methylthioadenosine 5′-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a Gi-independent Increase in cAMP Levels
- (2009) Subhashini Srinivasan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Limitations of current therapies to prevent thrombosis: a need for novel strategies
- (2009) Jean-Etienne Fabre et al. Molecular BioSystems
- Intravenous Platelet Blockade with Cangrelor during PCI
- (2009) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI
- (2009) Robert A. Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin
- (2009) S. C. Fox et al. PLATELETS
- P2Y1 receptor antagonists as novel antithrombotic agents
- (2008) Jeffrey A. Pfefferkorn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The reversible P2Y12antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function
- (2008) N. L. DOVLATOVA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease
- (2008) Stan Heptinstall et al. PLATELETS
- Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1and P2Y12receptors: A new finding that may influence the design of anti-thrombotic agents
- (2008) P. Manolopoulos et al. PLATELETS
- Role of P2Y receptor subtypes in platelet-derived microparticle generation
- (2007) Bryan et al. Frontiers in Bioscience-Landmark
- Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect
- (2007) Steven R. Steinhubl et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started